Bolt Biotherapeutics, Inc.

BOLT Nasdaq Healthcare · Pharmaceutical Preparations Redwood City, CA www.boltbio.com/
$6.42
Mkt Cap 12.4M

Clinical-stage biotechnology company developing immunotherapy treatments that harness the immune system to fight cancer.

boltbio.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$4.7M
101.6% CAGR
FCF TTM
-$31.5M
-670.7% margin
Running full 6-factor analysis…